The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026.
Oral Cancer Rapid Test Kit market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Cancer Rapid Test Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
According to #TechSci Research report, Global Rapid Test Kit Market stood at USD23.44 billion in 2020 and expected to grow at steady CAGR of 8.14% by 2026. Gain More Insight: https://bit.ly/3vEVaM0 Get Sample Report: https://bit.ly/37y0udo Press Release: https://bit.ly/3rzXsfK Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Rise in geriatric population base is a high impact rendering driver for this market, as the people of this age group demand quicker diagnosis and treatment.
The India Rapid IVD Kits Industry is estimated at USD 1.71 billion in 2024, with expectations to reach USD 2.34 billion by 2029, showcasing a robust CAGR of 6.58% during the forecast period (2024-2029).
The India Rapid IVD Kits Market Analysis was valued at USD 1.71 billion in 2024 and is projected to reach USD 2.34 billion by 2029, growing at a CAGR of 6.58%. This growth is attributed to the increased demand for rapid diagnostic methods and the rising prevalence of chronic conditions.
Rapid diagnostic tests, often known as RDTs are simple-to-use procedures that offer outcomes in within 20 minutes. Unlike most standard diagnostic tests, which are required to be sent to a lab for analysis, RDTs are performed and results are provided at the point-of-care.
The research firm Contrive Datum Insights has just recently added to its database a report with the heading global Clinical Laboratory Test Market .Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide Clinical Laboratory Test Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct
Breast cancer liquid biopsy market is expected to account to USD 1,212.02 million by 2027 expanding at a rate of 23.09% in the forecast period of 2020 to 2027. The market will witness rapid surge of market cap amid high incidence rate of cancer and increased expenditure from various authorities and market players on the R&D activities for advancing liquid biopsy technology.
This Cancer diagnostics market report is an exhaustive research on companies active in Cancer diagnostics sector, its applications, products, end-users, trends and predictions on how the market will grow in coming years.
The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021. Factors such as the growing prevalence of cancer and rapidly increasing geriatric population
According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18% during the period 2019-2029.
Future Market Insights (FMI), in its latest publication, outlines the future trajectory of the global nucleic acid isolation and purification market through 2029. According to the report, worldwide sales of nucleic acid isolation and purification kits were valued at ~US$ 830 million in 2018, and are estimated to register a Y-o-Y growth of ~4% in 2019.
Global Blood Screening Market, By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
According to #TechSci Research report, United States Patient At Home Testing Kits Market stood at USD3239.54 million in 2020 and is expected to grow at a CAGR of 7.94% during the forecast period. Gain More Insight: https://bit.ly/3gPK7JP Get Sample Report: https://bit.ly/3vwDtzo Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Molecular diagnostics, a rapidly evolving segment of the healthcare industry, utilizes molecular biology techniques to analyze biological markers at the molecular level. This approach enables precise detection, diagnosis, and monitoring of various diseases, leading to personalized treatment strategies and improved patient outcomes. The global molecular diagnostics market demonstrates robust growth, driven by technological advancements, increasing prevalence of infectious diseases and cancer, and growing demand for rapid and accurate diagnostic solutions. The global molecular diagnostics market is forecast to expand at a CAGR of 6.2% and thereby increase from a value of US$23.2 Bn in 2024, to US$35.6 Bn by the end of 2031.
In the manufacturing process, pyrogen testing is the necessary step to remove or deactivate possible bacterial pollutants. Leading to rapid growth in the pharmaceutical and biotechnology industry and a rising number of new drug releases, the global Pyrogen Testing Market is growing at a substantial pace. Due to mounting introduction of kit-based research and recurrence purchasing of kits and reagents relative to tools, the industry has seen strong demand for kits and reagents in the coming years.
According to a new market research report "Drug Screening Market by Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat) - Global Forecast to 2019", published by MarketsandMarkets, the global Drug and Alcohol Testing Market is expected to reach $6.3 Billion by 2019 from $4 Billion in 2014, growing at a CAGR of 9.5% from 2014 to 2019.
Global Blood Screening market size was USD 3.61 Billion in 2022 and it is forecasted to reach USD 5.14 Billion by 2030. Blood Screening Industry's Compound Annual Growth Rate will be 8.5% from 2023 to 2030.
Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025. Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform & Consumable" provides Next Generation Sequencing Market. Access full Research: https://www.renub.com/next-generation-sequencing-market-p.php
Increasing investment in R&D in molecular diagnostics, new product development, and rising prevalence of targeted diseases are some key factors driving market revenue growth.
The global blood testing market is estimated to garner around USD 140 billion in revenue by the end of 2031 by growing at a CAGR of nearly 8% throughout the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing prevalence of infectious and chronic diseases, such as COVID-19, influenza, diabetes, cardiovascular diseases, liver diseases, and various cancers.
The global Glycomics/Glycobiology market size reached USD 1.51 Billion in 2021 and is expected to register a revenue CAGR of 15.4% during the forecast period, according to latest analysis by Emergen Research. Increasing application of quantitative glycomics in clinical settings, rising potential of glycan biomarkers for prognosis and diagnosis of various diseases, as well as rapid technological advancements in glycomics/glycobiology field such as high-throughput serum glycomic profiling are some of the key factors driving the market revenue growth of the Glycomics/Glycobiology market.
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018 @ http://www.reportsnreports.com/reports/280675-tissue-diagnostics-market-by-technology-immunohistochemistry-in-situ-hybridization-digital-pathology-workflow-special-staining-disease-breast-cancer-gastric-cancer-lymphoma-prostate-cancer-non-small-cell-lung-cancer-and-others-product-instruments.html Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer.
PREDICTIVE testing for monogenic, late-onset disorders such as HUNTINGTON'S disease; ... to teach a class on genetics, he read a pamphlet on Huntington's Disease ...
According to the latest research report by IMARC Group, The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market
The research firm Contrive Datum Insights has just recently added to its database a report with the heading global IVD Market . Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide IVD Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct, and presented in a professional manner.
The rising prevalence of Leukemia and Multiple myeloma and the increasing awareness among patients and healthcare professionals about initial diagnosis are driving the demand for the market.
Increase in burden of cancer globally, growing demand for personalized medicine and targeted therapy coupled with increase in adoption of drug diagnostics co-development model by industry players are the key factors driving the global companion diagnostics market.
Beckman Coulter Inc. Great Lakes Cancer Institute. Ingham Regional Medical Center ... ( Ann Arbor), Frenchtown Senior Center (Monroe), JC Penney Retirees (Monroe) ...
The rise in the prevalence of hematologic cancer, increment in knowledge of precision medicine and the increase in the amount of assays are likely to result in the rapid growth of the oncology research industry in the forecast years.
Overview of Predictive Genetic Testing & Consumer/Wellness Genomics Market Report Helps In Providing Scope and Definitions, Key Findings, Growth Drivers, and Various Dynamics.
Increasing investment in R&D in molecular diagnostics, new product development, and rising prevalence of targeted diseases are some key factors driving market revenue growth.
ELISpot and FluoroSpot Assays Industry Research Report Analysis by MRFR. The Market is expected to Reach USD 287 Million by 2023. The Global Market Analysis by Product, Application, End User, and Region - Forecast till 2023
According to the Market Statsville Group (MSG), the global nucleic acid isolation & purification market size is expected to grow from USD 6,331.6 million in 2021 to USD 12,241.2 million by 2030, at a CAGR of 7.6% from 2022 to 2030. Isolation and purification of nucleic acids are critical for expanding medical applications such as research, medication discovery, and others.
A new market study based on the Point Of Care Diagnostics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.
Request a case study or sample research report @ https://precisionbusinessinsights.com/request-sample?product_id=17104 The Global Point of Care Diagnostics market size was valued at USD 27.66 billion in the year 2020 and is anticipated to record a CAGR of 3.25% during the overcast period 2021-2027. Competitive Analysis: Industry players follow some effective strategies to increase the revenue share in the market. A few of the prominent key players operating in point of care diagnostics market include Siemens AG (Germany), Abbott Laboratories, Inc.
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100000820 According to a new market research study titled 'Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.
For more Info: https://www.renub.com/global-biopsy-devices-market-nd.php Biopsy devices market is eminently fuelling due to the rising demand for less invasive procedures and the increasing incidence of cancer across the globe. Biopsy is a procedure of taking out a piece of tissue (sample) of cells from one’s body so that it can be studied further in a laboratory. Most often, doctor suggests having a biopsy done to determine whether one has cancer or some other condition. Global Biopsy Devices Market will reach US$ 3 Billionby the year 2024, according to Renub Research’s new report. A biopsy is one of the key diagnostic procedures performed during the diagnosis of any cancer. Though, other relevant tests may suggest that the cancer is present, but only a biopsy can make a perfect diagnosis. Doctors may recommend a biopsy when they find something doubtful in a person’s physical or other tests finding.
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.